Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Mar 2026 and Apr 2026.
- Largest single sale: $753K (30,000 shares) of Teva Pharmaceutical Industries Ltd on Nov 14, 2025. Filing
- Last sale before this period: Mar 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | EVP, U.S. Commercial | Nov 22, 2023 | May 4, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Apr 30, 2026, Teva Pharmaceutical Industries Ltd: sold 21,258 shares for $751K, no plan disclosed. 1 filing: 1
- Mar 5, 2026, Teva Pharmaceutical Industries Ltd: sold 7,924 shares for $251K, under a disclosed plan; 17,819 shares vested. 1 filing: 1
- Mar 4, 2026, Teva Pharmaceutical Industries Ltd: sold 9,098 shares for $295K, under a disclosed plan; 20,461 shares vested. 1 filing: 1
- Nov 20, 2025, Teva Pharmaceutical Industries Ltd: sold 28,229 shares for $700K, under a disclosed plan; 63,492 shares vested. 1 filing: 1
- Nov 14, 2025, Teva Pharmaceutical Industries Ltd: sold 30,000 shares for $753K, no plan disclosed. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.